Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial
V Fonseca, J Rosenstock, R Patwardhan, A Salzman - Jama, 2000 - jamanetwork.com
ContextMost antidiabetic agents target only 1 of several underlying causes of diabetes. The
complementary actions of the antidiabetic agents metformin hydrochloride and rosiglitazone
maleate may maintain optimal glycemic control in patients with type 2 diabetes; therefore,
their combined use may be indicated for patients whose diabetes is poorly controlled by
metformin alone. ObjectiveTo evaluate the efficacy of metformin-rosiglitazone therapy in
patients whose type 2 diabetes is inadequately controlled with metformin alone …
complementary actions of the antidiabetic agents metformin hydrochloride and rosiglitazone
maleate may maintain optimal glycemic control in patients with type 2 diabetes; therefore,
their combined use may be indicated for patients whose diabetes is poorly controlled by
metformin alone. ObjectiveTo evaluate the efficacy of metformin-rosiglitazone therapy in
patients whose type 2 diabetes is inadequately controlled with metformin alone …
以上显示的是最相近的搜索结果。 查看全部搜索结果